Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis

Fig 5

Kolmogorov–Smirnov test to determine the normality of the data for the relative change in predicted FVC from baseline.

The data were normally distributed.

Fig 5

doi: https://doi.org/10.1371/journal.pone.0236935.g005